Ardelyx CMO Appointment Tests Growth Plans For Tenapanor Based Therapies [Yahoo! Finance]
Ardelyx, Inc. (ARDX)
Last ardelyx, inc. earnings: 3/6 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.ardelyx.com/investor-relations
Company Research
Source: Yahoo! Finance
Ardelyx (NasdaqGM:ARDX) appointed Rajani Dinavahi, MD, as Chief Medical Officer. Dr. Dinavahi brings experience in drug development and global leadership in biotechnology. Her background includes advancing therapies from early development through regulatory approval across multiple therapeutic areas. Ardelyx, trading at $5.94, has seen a 30.5% return over the past year and a 35.0% return over the past three years, while the five year return stands at a 20.2% decline. The recent one week return of 8.4% contrasts with declines of 5.3% over the past 30 days and 3.4% year to date, reflecting mixed shorter term sentiment around the stock. Ardelyx management has described the company as entering a key growth phase. Within this context, Dr. Dinavahi's experience in nephrology and immunology oriented drug development may influence how the company prioritizes its research pipeline. Investors watching NasdaqGM:ARDX may monitor future clinical and regulatory updates as her leadership is
Show less
Read more
Impact Snapshot
Event Time:
ARDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARDX alerts
High impacting Ardelyx, Inc. news events
Weekly update
A roundup of the hottest topics
ARDX
News
- Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026GlobeNewswire
- Is Ardelyx (ARDX) Offering Long-Term Value After Recent Share Price Swings? [Yahoo! Finance]Yahoo! Finance
- Ardelyx President and CEO Sells 41,000 Shares for $243,000 [Yahoo! Finance]Yahoo! Finance
- Rajani Dinavahi, MD, Appointed Chief Medical Officer of ArdelyxGlobeNewswire
- Ardelyx (ARDX) was given a new $17.00 price target by Williams Trading.MarketBeat
ARDX
Earnings
- 2/19/26 - Miss
ARDX
Sec Filings
- 4/17/26 - Form 4
- 4/3/26 - Form 3
- 3/26/26 - Form SCHEDULE
- ARDX's page on the SEC website